Loperamide Hydrochloride

• Efficacy and safety of a novel dual pH-dependent delayed-release ColeseveLam for the trEatment of bile Acid diarrhoea: a Randomized, double-… Pending
  2025-523868-20-00 Phase II 1 country Monteresearch S.r.l.
• PHASE IB/II STUDY TO EVALUATE SAFETY AND PRELIMINARY EFFICACY OF ZANIDATAMAB IN COMBINATION WITH TUCATINIB AND CHEMOTHERAPY (CAPECITABINE OR… Pending
  2025-524613-89-00 Phase I/II 1 country Medica Scientia Innovation Research S.L.
• Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis Recruiting
  2023-504724-25-00 Phase III 13 countries Kartos Therapeutics Inc.
• Acute Subcutaneous Semaglutide in Acute Ischemic Stroke (ASSET Trial) Recruiting
  2022-501072-25-02 Phase II 1 country Aarhus University Hospital
• Intra-arterial hepatic (IAH) infusion of radiolabelled somatostatin analogs in GEP-NET patients with dominant liver metastases Recruiting
  2024-514785-39-00 Phase II 1 country Centre Hospitalier Universitaire De Bordeaux
• Phase II study to evaluate diarrhoea discontinuations at 3 cycles in patients with early-stage HER2 positive, hormone receptor positive brea… Ended
  2024-514630-21-00 Phase II 4 countries Fundacion Grupo Espanol De Investigacion En Cancer De Mama
• Phase 2/3 Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer Ended
  2022-502196-31-00 Phase II/III 15 countries Kartos Therapeutics Inc.
• Multicenter, Open-label, Single arm, Phase II Clinical Trial to Improve Sacituzumab Govitecan Tolerance in Patients with Metastatic Triple-N… Ended
  2024-514060-10-00 Phase II 1 country Medica Scientia Innovation Research S.L.

Showing 1–8 of 8 trials